HITC — Healthcare Integrated Technologies Income Statement
0.000.00%
Last trade - 00:00- $8.12m
- $8.73m
- 24
- 11
- 58
- 21
Annual income statement for Healthcare Integrated Technologies, fiscal year end - July 31st, USD millions except per share, conversion factor applied.
2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0 | 0 | — | — | — |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.784 | 1.02 | 1.22 | 1.14 | 0.962 |
| Operating Profit | -0.784 | -1.02 | -1.22 | -1.14 | -0.962 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.823 | -1.06 | -1.46 | -1.36 | -1.3 |
| Net Income After Taxes | -0.823 | -1.06 | -1.46 | -1.36 | -1.3 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -0.839 | -1.06 | -1.46 | -1.36 | -1.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.839 | -1.06 | -1.46 | -1.36 | -1.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.025 | -0.032 | -0.04 | -0.032 | -0.03 |